<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8918110</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2607</journal-id>
<journal-id journal-id-type="nlm-ta">Eur J Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Eur. J. Neurosci.</journal-id>
<journal-title-group>
<journal-title>The European journal of neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">0953-816X</issn>
<issn pub-type="epub">1460-9568</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27364953</article-id>
<article-id pub-id-type="pmc">5012961</article-id>
<article-id pub-id-type="doi">10.1111/ejn.13329</article-id>
<article-id pub-id-type="manuscript">NIHMS799671</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Partial inactivation of GABA<sub>A</sub> receptors containing the α5 subunit affects the development of adult-born dentate gyrus granule cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Deprez</surname>
<given-names>Francine</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN2">¥</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vogt</surname>
<given-names>Fabia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN2">¥</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Floriou-Servou</surname>
<given-names>Amalia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lafourcade</surname>
<given-names>Carlos</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rudolph</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tyagarajan</surname>
<given-names>Shiva K.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fritschy</surname>
<given-names>Jean-Marc</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>University of Zurich, Institute of Pharmacology and Toxicology, 8057 Zurich, Switzerland</aff>
<aff id="A2"><label>2</label>Neuroscience Center Zurich, ETH and University of Zurich</aff>
<aff id="A3"><label>3</label>Laboratory of Genetic Neuropharmacology, McLean Hospital, Belmont, MA, U.S.A</aff>
<aff id="A4"><label>4</label>Department of Psychiatry, Harvard Medical School, Boston, MA, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding author: University of Zurich, Institute of Pharmacology and Toxicology, Winterthurerstrasse 190, 8057 Zurich, Switzerland; Tel. +41 44 635 5926; <email>fritschy@pharma.uzh.ch</email></corresp>
<fn fn-type="equal" id="FN2">
<label>¥</label>
<p>Equal contribution</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>44</volume>
<issue>5</issue>
<fpage>2258</fpage>
<lpage>2271</lpage>
<!--elocation-id from pubmed: 10.1111/ejn.13329-->
<abstract>
<p id="P1">Alterations of neuronal activity due to changes in GABA<sub>A</sub> receptors (GABA<sub>A</sub>R) mediating tonic inhibition influence different hippocampal functions. <italic>Gabra5</italic>-null mice and α5 subunit<sup>(H105R)</sup> knock-in mice exhibit signs of hippocampal dysfunction, but are capable of improved performance in several learning and memory tasks. Accordingly, alleviating abnormal GABAergic tonic inhibition in the hippocampal formation by selective α5-GABA<sub>A</sub>R modulators represents a possible therapeutic approach for several intellectual deficit disorders. Adult neurogenesis in the dentate gyrus is an important facet of hippocampal plasticity; it is regulated by tonic GABAergic transmission, as shown by deficits in proliferation, migration, and dendritic development of adult-born neurons in <italic>Gabra4</italic>-null mice. Here, we investigated the contribution of α5-GABA<sub>A</sub>Rs to granule cell development, using retroviral vectors expressing eGFP for labeling precursor cells in the subgranular zone. Global α5-GABA<sub>A</sub>R knockout (α5-KO) mice showed no alterations in migration and morphological development of eGFP-positive granule cells. However, upregulation of α1 subunit-immunoreactivity was observed in the hippocampal formation and cerebral cortex. In contrast, partial gene inactivation in α5-heterozygous (α5-het) mice, as well as single-cell deletion of <italic>Gabra5</italic> in newborn granule cells from α5-floxed mice, caused severe alterations of migration and dendrite development. In α5-het mice, retrovirally-mediated overexpression of Cdk5 resulted in normal migration and dendritic branching, suggesting that Cdk5 cooperates with α5-GABA<sub>A</sub>Rs to regulate neuronal development. These results show that minor imbalance of α5-GABA<sub>A</sub>R-mediated transmission may have major consequences for neuronal plasticity; and call for caution upon chronic therapeutic use of negative allosteric modulators acting at these receptors.</p>
</abstract>
<kwd-group>
<kwd>adult neurogenesis</kwd>
<kwd>Cdk5</kwd>
<kwd>dendrites</kwd>
<kwd>migration</kwd>
<kwd>retrovirus</kwd>
<kwd>targeted gene deletion</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>